Explore Articles
The complete collection

Explore the peptide library.

In-depth, accessible articles on foundational biology, emerging research, medical therapies, and evidence standards. Every article includes source links and safety context.

Foundations

Peptides, explained

What peptides are, how they differ from proteins, and why a small chain of amino acids can have an outsized biological effect.

Foundations

How peptides work in the body

A closer look at receptors, signalling pathways, peptide breakdown, and the limits of simplified biological explanations.

Therapies

GLP-1 medicines and metabolic health

Why incretin-based treatments are a major development, what the evidence demonstrates, and where common misconceptions begin.

Research watch

BPC-157: claims versus clinical evidence

A careful examination of tissue repair claims, animal studies, missing human data, and regulatory concerns.

Research watch

TB-500 and thymosin beta-4 research

Understand the relationship between thymosin beta-4 and products described as TB-500, with a focus on evidence and safety.

Skin science

GHK-Cu and the science of skin peptides

Explore copper-binding peptides, the differences between topical research and injections, and what cosmetic claims really mean.

Research watch

CJC-1295 and ipamorelin: growth hormone pathways

What growth hormone secretagogues aim to influence and why safety, evidence, and sport rules demand caution.

Delivery systems

Dual-chamber peptide pens: the next generation of drug delivery

Why dual-chamber designs are attracting attention, how they can protect sensitive formulations, and when an integrated pen may offer meaningful advantages.

Clinical trials

Clinical trials: breakthrough results in peptide medicine

Explore standout human trials of semaglutide and tirzepatide, including outcomes in weight management, cardiovascular health, and chronic kidney disease.

Article categories describe topics, not treatment recommendations. Authorizations and safety information may change. Always consult official sources for current status.